8thANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE:An Intensive Course on Translating Research into Drugs
the Miami Beach Resort in Miami Beach
4833 Collins Avenue
Miami Beach, Florida USA
8thANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE:An Intensive Course on Translating Research into Drugs 
Alzheimer's Drug Discovery 
the Miami Beach Resort in Miami Beach
4833 Collins Avenue
Miami Beach
Florida  USA

Schedule of Presentations:

Sunday, February 2, 2014
10:10:00 Q&A
10:20:00 Natural Products as Drug Starting Points Frank E. Koehn
16:20:00 Plenary – Functional Approaches to CNS Drug Discovery and the Potential for Drugs with Multiple Targets as a Mechanism of Action
17:05:00 Q&A Howard Fillit
17:15:00 Closing Remarks Howard Fillit
17:20:00 Welcoming Reception
Monday, February 3, 2014
08:00:00 Continental Breakfast
08:30:00 Welcome & Opening Remarks Lorenzo Refolo
08:35:00 Preclinical Therapeutics Development for Neurological Disorders: Funding & Resources Lorenzo Refolo, Patricia Ann Walicke
08:50:00 Overview: Themes in Successful Prior Art for Novel Small Molecule Discovery in CNS Disorders D Martin Watterson
09:25:00 Q&A
09:35:00 Synthetic Chemistry Fundamentals in Lead Compound Refinement J. Pelletier
10:40:00 Q&A
10:50:00 Break
11:20:00 II. Embarking on a Drug Discovery Campaign Kalpana Merchant
11:25:00 Improving Clinical Success Through Optimal Target Identification and Validation Kalpana Merchant
11:45:00 Q&A
11:55:00 Using Chemical Probes for Target Validation and to Understand Target Liability
12:15:00 Q&A
12:25:00 Assembling the Right Interdisciplinary Team From the Beginning Julie Frearson
12:45:00 Q&A
12:55:00 Lunch and Poster Session
13:55:00 III. Drug Discovery: From Screening to Clinical Candidate Edward Spack
14:00:00 New Trends in High Throughput Screening (HTS) Thomas Kodadek
14:20:00 Q&A
14:30:00 Compound Optimization after HTS: From Hit to Lead Kurt R. Brunden
14:50:00 Q&A
15:00:00 Designing a Therapeutic Animal Study: Employing Translatable Biomarkers Manfred Windisch
15:20:00 Q&A
15:50:00 Break
16:10:00 Requirements for an IND and Early Considerations Edward Spack
16:30:00 Q&A
16:40:00 When Should You Engage a Contract Research Organization? Katya Tsaioun
17:10:00 Q&A
17:20:00 ADDF ACCESS Program and Closing Remarks Rachel Lane
17:30:00 Networking Reception and Poster Session
Tuesday, February 4, 2014
06:00:00 New Presentation
06:00:00 New Presentation
08:00:00 Continental Breakfast
08:30:00 Welcome & Opening Remarks Diana Shineman
08:35:00 Plenary – The Story of Lyrica: Academic Discovery to Commercial Success Rick Silverman
09:05:00 Q&A
09:15:00 IV. Strategies for Challenging CNS Targets – Case Study Examples Marcie Glicksman
09:20:00 Case Study: From Bench to High Throughput Screen Marcie Glicksman
09:40:00 Q&A
09:50:00 Innate Immune Modulatory Strategies for ALS and Alzheimer's Todd Golde
10:10:00 Q&A
10:20:00 Development of Small Molecule Hepatocyte Growth Factor Mimetic for the Treatment of Dementia
10:40:00 Q&A
10:50:00 Break
11:10:00 Allopregnanolone: From Laboratory Discovery to Clinical Trial Roberta Diaz Brinton
11:30:00 Q&A
11:40:00 BACE Inhibition for Alzheimer's Disease: Validation of Target Engagement Mark Forman
12:00:00 Q&A
12:10:00 Lunch and Poster Session
13:10:00 V. Developing Science into Products Kurt R. Brunden
13:15:00 Novel Approaches to Technology Transfer: Pharma-Academia Collaborations Robert A. Zivin
13:35:00 Q&A
13:45:00 Innovation in Tech Transfer and the Role of the Tech Transfer Office
14:05:00 Q&A
14:15:00 A Re-Understanding of How to Protect and use Intellectual Property
14:35:00 Q&A
14:45:00 Break
15:05:00 VI. What do Partners Looks For? A Perspective from Pharma, Private Investors and Philanthropy Frank Longo
15:20:00 Panel Discussion: What do Partners Look For? Marco Baptista
16:00:00 Closing Remarks Howard Fillit
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.